• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35SX060080135
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Occlusion (1984)
Event Date 04/25/2017
Event Type  Injury  
Manufacturer Narrative
The patient required revascularization of the treated lesion.This is being reported as a follow-up to the clinical registry.Patient information regarding relevant tests or laboratory data is unknown.This information was not available from the facility.Stellarex 0.035 otw drug-coated angioplasty balloon, paclitaxel drug, 3.2 mg, therapy date: (b)(6) 2016, the stellarex 0.035¿ otw drug-coated angioplasty balloon is indicated for the treatment of de-novo or re- stenotic lesions in the lower extremities to establish blood flow and to maintain vessel patency.Lot #: fxz16g13a, expiration date: 07/21/2018, (b)(4).(b)(6).Pma number is not applicable.The device is commercial product with a ce mark that was used as part of a clinical registry./ combination product is applicable during the index procedure, the product worked as intended, thus no product evaluation was required.Per the ifu, restenosis is listed as a potential complications/adverse events.
 
Event Description
It was reported through a clinical registry that during the index procedure on (b)(6) 2016, four stellarex catheters were used to treat the target lesion of the left proximal, mid, and distal sfa and pop.Approximately 5 months post index procedure, the patient experienced an occlusion.A successful revascularization of the target lesion was performed on (b)(6) 2017.The physician indicated this is not related to the study device or procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
fremont CA
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
florie cazem
5055 brandin court
fremont, CA 94538
510933-792
MDR Report Key7141220
MDR Text Key95593911
Report Number3009784280-2017-00119
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 12/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/21/2018
Device Model NumberA35SX060080135
Device Catalogue NumberA35SX060080135
Device Lot NumberFXZ16G13A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2017
Initial Date FDA Received12/21/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MFG AND SIZE UNK: GUIDE CATHETER; MFG AND SIZE UNK: GUIDE WIRE; MFG AND SIZE UNK: INTRODUCER SHEATH
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
Patient Weight93
-
-